Young Women with Cervical Precancer Face Elevated Heart Disease Risk, Nationwide Study Finds
Cervical high-grade squamous intraepithelial lesion, or HSIL, is typically understood as a precancerous condition - cells on the cervix that have undergone abnormal changes and, if untreated, can progress to invasive cervical cancer. Treatment usually involves removing the abnormal tissue. The cardiovascular implications of the diagnosis, if any, have not been a focus of clinical attention.
A nationwide study from Sweden, published in JAMA Oncology, raises a question that has not previously been examined systematically: do young women diagnosed with HSIL face an elevated risk of cardiovascular disease beyond what would be expected for their age group? The answer, according to this analysis, appears to be yes - though the mechanism is not yet established and the findings are considered preliminary.
What the study examined
The research team, led by Laila Hubbert, MD, PhD, at Linkoping University, conducted a nationwide cohort analysis drawing on Swedish registry data. Adolescents and young adults with a prior HSIL diagnosis were compared against matched controls without the diagnosis across a range of cardiovascular outcomes and mortality endpoints. The nationwide scope and registry-based design allowed the researchers to include a large population and follow participants over time.
The central finding was that women with prior HSIL faced increased cardiovascular disease risk and mortality compared to their matched controls. The elevated risk was present in this young age group - a population not typically screened or assessed for cardiovascular risk factors.
Why the connection is unexpected - and unexplained
HSIL results from persistent infection with high-risk strains of human papillomavirus (HPV). HPV is also associated with certain cancers beyond the cervix, including oropharyngeal, anal, and vulvar cancers. Whether HPV infection, the inflammatory response it provokes, or the treatments used to address HSIL might have downstream effects on cardiovascular health is not established by this study - it identifies an association, not a cause.
Several biological pathways could theoretically connect HSIL or its underlying viral cause to cardiovascular risk. Chronic inflammation is a known contributor to atherosclerosis and cardiovascular disease. Some HPV strains trigger persistent immune activation. Treatments involving excision of cervical tissue may also have effects on overall physiology that are not fully characterized. The study does not adjudicate between these possibilities.
Clinical implications and current limitations
The authors are careful to note that the findings warrant further research before they can inform clinical practice. The elevated risk observed in this population supports heightened awareness among clinicians caring for women with prior HSIL, but does not establish a specific screening protocol or intervention. More research is needed to understand whether the association is causal, what biological mechanism might explain it, and whether it differs by treatment type, HPV strain, or other patient characteristics.
A key limitation of the registry-based design is that it cannot fully control for all potential confounders - lifestyle factors, socioeconomic status, and access to healthcare may differ between HSIL patients and matched controls in ways that were not captured in the available data. The magnitude of the elevated risk and its clinical significance will require further characterization in studies with richer covariate data.
The finding adds to a growing recognition that the boundaries between gynecological oncology and cardiovascular medicine may be less distinct than previously assumed. Young women with prior HSIL represent a population where cardiovascular risk evaluation and preventive care may deserve more attention than they currently receive.